Nanite, Inc.
PrivateLast Round
Grant
May 8, 2024
Total Funding Raised
$11.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nanite, Inc. operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Grant round in May 2024.
Nanite, Inc. is a biotechnology company that develops programmable polymer nanoparticles for non-viral gene delivery using an AI-driven platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanite, Inc. Comparables
Compare Nanite, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Envoya | 86% | |
| Liberate Bio | 83% | |
| Hopewell Therapeutics | 83% |
For institutional investors. Book with your work email.
Nanite, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 8, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Grant | Aug 10, 2023 | ||||
| Grant | Mar 15, 2023 | ||||
| Seed | Feb 15, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanite, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zetta Venture Partners | Seed |
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Cystic Fibrosis Foundation | Grant |
| Arkitekt Ventures | Seed |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 58% MoM.
- Jul 25, 2026
Monthly visitors grew 2930% MoM, from 50 to 1.5K.
For institutional investors. Book with your work email.
Nanite, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanite, Inc.'s valuation, stock price, and market status.
Is Nanite, Inc. a public or private company?
Nanite, Inc. is a private company.
What is the current stock price of Nanite, Inc.?
Nanite, Inc. is a private company, so its shares have no public market price. Caplight tracks Nanite, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanite, Inc. worth (valuation)?
Valuation information for Nanite, Inc. is not publicly available.
Can I buy Nanite, Inc. stock?
Nanite, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanite, Inc.'s last funding round?
Nanite, Inc.'s most recent funding round was Grant on May 8, 2024.
Who are the main investors in Nanite, Inc.?
Key investors in Nanite, Inc. include Zetta Venture Partners, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute.
Will Nanite, Inc. IPO soon?
No public IPO plans have been announced for Nanite, Inc..
How can I track Nanite, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Nanite, Inc.'s shares on secondary markets.